 GERMANTOWN, Md., Oct. 12, 2021 PRNewswire -- Precigen, Inc. Nasdaq: PGEN, a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the appointment of Harry Thomasian Jr. as the Companys chief financial officer CFO, effective October 18, 2021. 